Lecanemab is the first drug to change the course of Alzheimer’s disease, but two deaths during its clinical trial have raised questions about the drug’s safety.
Chinese New Year is right around the corner, and contributor Ella Gerry takes the opportunity to explore the significance of the pig in science research.